Article Versions Notes

Fabbroni C, Fucà G, Ligorio F, Fumagalli E, Barisella M, Collini P, Morosi C, Gronchi A, Dei Tos AP, Casali PG, et al. Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin. Cancers. 2021; 13(6):1453. https://doi.org/10.3390/cancers13061453

Fabbroni, Chiara, Giovanni Fucà, Francesca Ligorio, Elena Fumagalli, Marta Barisella, Paola Collini, Carlo Morosi, Alessandro Gronchi, Angelo Paolo Dei Tos, Paolo Giovanni Casali, and et al. 2021. "Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin" Cancers 13, no. 6: 1453. https://doi.org/10.3390/cancers13061453

Fabbroni, C., Fucà, G., Ligorio, F., Fumagalli, E., Barisella, M., Collini, P., Morosi, C., Gronchi, A., Dei Tos, A. P., Casali, P. G., & Sanfilippo, R. (2021). Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin. Cancers, 13(6), 1453. https://doi.org/10.3390/cancers13061453